loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 9089607

    Client Virtual Booth
    Menu

    Impax Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 IMPAX LABS INC (8)

    filter

    01 9089607 (8)

    filter

    01 Blank (8)

    filter

    01 Y (8)

    filter

    01 2028-12-26 (8)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1645
    203312
    TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1645
    203312
    TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1645
    203312
    TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1720
    203312
    METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1645
    203312
    TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICAT
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1720
    203312
    METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1720
    203312
    METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    IMPAX LABS INC

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARBIDOPA; LEVODOPA

    PDF Supplier PDF
    URL Supplier Web Content
    9089607
    Y
    2028-12-26
    U-1720
    203312
    METHOD OF PROVIDING A THERAPEUTICALLY EFFECTIVE AND STABLE MEDIAN BLOOD PLASMA LEVEL OF LEVODOPA
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY